The Daily Papule

Meeting abstracts

AAD 2026

American Academy of Dermatology · Denver, 27–31 March 2026

1,877 abstracts, published in JAAD on 6 July 2026. Their text is on the JAAD website.

  1. 71032

    Evaluating Etanercept for the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

    Yoon I, Natarelli N, … senior author Lin A

  2. 71239

    Successful management of pembrolizumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap with upadacitinib

    Goetz L, Wang B

  3. 72198

    Xylazine-Induced Skin Necrosis: A Systematic Review

    Roecker A, Nguyen K, … senior author Linfante A

  4. 72321

    Cutaneous immune-related adverse events in people living with HIV receiving immune checkpoint inhibitors for advanced malignancy

    Corey S, Thompson BB, … senior author Chen ST

  5. 72329

    The use of topical ruxolitinib in the treatment of localized, steroid-refractory cutaneous immune-related adverse events: A single-institution real-life study

    Block B, Mehta J, … senior author Gulati N

  6. 72455

    Cutaneous Toxicity Patterns and Clinical Outcomes in Patients Treated with Pegylated Liposomal Doxorubicin (PLD): A Multi-Cancer Cohort Study

    Bui T, Shafagati N, … senior author Sterling C

  7. 72509

    Association of Dupilumab Use with Acute Care Utilization and Mortality Outcomes Among Patients with Cutaneous Immune-Related Adverse Events: A Global TriNetX Database Study

    Block B, Mehta J, Gulati N

  8. 72990

    CaSMO recommendations for prevention and treatment of cutaneous adverse events related to cancer therapies in darker skin phototypes

    Fournier C, Sauder M, … senior author Lynde CW

  9. 73288

    Interface Change in Non-Lesional Skin as a Histopathologic Precursor to Stevens-Johnson Syndrome in a Patient on Enfortumab Vedotin: A Case Report

    Dubin C, Block B, … senior author Gulati N

  10. 73698

    Risk of Psychiatric Disorders Following Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Database Study

    Cheever CR, Ching LM, … senior author Ziemer CM

  11. 73834

    Retrospective Evaluation of Immunomodulating Therapies in the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Burn ICU

    Chyung K, Wang A, … senior author Newman S

  12. 73842

    Outbreak of Stevens-Johnson syndrome/Toxic epidermal necrolysis in Singapore secondary to illicit, off-label use of Armodafanil: A report of 5 cases

    Lee HY, Chai ZT, … senior author Oh CC

  13. 74061

    Dupilumab in lichen planus and dupilumab-induced lichenoid drug eruption: A systematic review

    Te B, Udupa M, … senior author Liu C

  14. 74142

    Management of hand-foot skin reaction related paronychia secondary to EGFR-directed therapies: an assessment of topical, oral, and procedural therapies

    Lu K, Cheng M, … senior author Dobry A

  15. 74151

    Characterizing immune checkpoint inhibitor-associated vitiligo: a single-institution cohort

    Lu K, Enriquez K, Dobry A

  16. 74155

    Characterizing dermatologic toxicities of novel agents for patients with EGFR exon 20 insertion mutations in NSCLC

    Lu K, Cheng M, … senior author Dobry A

  17. 74372

    Do GLP-1s SCAR? A FAERS Disproportionality Analysis of Severe Cutaneous Adverse Reactions to GLP-1 Receptor Agonists

    Levin N, Jacobs J, Usmani A

  18. 74589

    Drug-Induced Paronychia: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System

    Maniam G, Le D, Nguyen G

  19. 74655

    Stevens-Johnson Syndrome and Toxic Epidermal Necrosis: Understanding Cardiovascular Risk using a Retrospective Analysis

    Patel D, Thakker S, … senior author Harp J

  20. 75023

    Antiseizure Drug-Associated Drug Reaction with Eosinophilia and Systemic Symptoms in a U.S. Single-center Cohort

    Pureesrisak P, Jaroenpuntaruk V, … senior author Pongdee T

  21. 75025

    Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Hospitalizations in the United States

    Razi S, Agarwal P, … senior author Rao B

  22. 75298

    Immune checkpoint inhibitor-related psoriatic arthritis: systemic steroid overuse and recommendations for targeted therapeutic alternatives

    Hanrahan G, Said J, … senior author LeBoeuf N

  23. 75319

    Human-in-the-Loop LLM for Faster and More Reliable Identification of Cutaneous Immune-Related Adverse Events

    Lu C, Burke O, … senior author Semenov Y

  24. 75357

    Impact of Cutaneous Immune-Related Adverse Event Morphology on Survival Outcomes in Patients with Cutaneous Malignancy: A TriNetX Database Study

    Gulati N, Mehta J, Block B, et al.

  25. 75387

    PD1/PDL-1 staining does not correlate with drug exposure in drug-induced cutaneous lichenoid eruptions

    Mager L, Johnson K, … senior author Dulmage B

  26. 75691

    Acneiform Eruption as A Reported Adverse Effect of Antidepressants: A Systematic Review

    Idris H, Kamboj S, … senior author Blalock T

  27. 75698

    Retrospective sex-based analysis of DRESS syndrome and specific organ involvement in a cohort of 185 patients

    Dewey E, Biba U, … senior author Mostaghimi A

  28. 75771

    Reported Patterns and Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Novel Antineoplastic Therapies: A Retrospective Pharmacovigilance Analysis

    Mahajan A, Pathak GN, … senior author Rao BK

  29. 75939

    The Utility of Diagnostic Testing in Symmetrical Drug-Related Intertriginous and Flexural Exanthema

    Jung J, Faulk C, … senior author Davis L

  30. 76054

    Characterizing Clinical Features and Comorbidities of Pediatric Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A National Inpatient Database Analysis

    Pathak G, Razi S, … senior author Rao B

  31. 76069

    Assessing the Impact of COVID-19 on SJS/TEN Hospitalizations based on the National Inpatient Sample

    Razi S, Agarwal P, … senior author Rao B

  32. 76079

    Inpatient complications and outcomes associated with Drug Reaction with Eosinophilia and systemic symptoms (DRESS) syndrome: A retrospective analysis of the Nationwide Inpatient Sample

    Pathak G, Razi S, … senior author Rao B

  33. 76211

    Challenges in culprit drug identification in DRESS syndrome

    Salloum L, Dewey E, … senior author Mostaghimi A

  34. 76234

    Characterizing epidemiology and demographics of DRESS Syndrome: Insights from a large cohort study

    Salloum L, Dewey E, … senior author Mostaghimi A

  35. 76277

    Rates of Psychiatric Comorbidities in Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

    Anderson B, Harrigan K, … senior author Patel T

  36. 76383

    Preexisting Autoimmune and Allergic Conditions in Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Analysis

    Seiff T, Casterline B, Trempy K

  37. 76399

    Cutaneous Adverse Events from Immune Checkpoint Inhibitors: A Review of Clinical Patterns and Management Strategies

    Wahab G, Wojtara M, … senior author Cooper A

  38. 76533

    Upadacitinib for Steroid-Refractory Immune-Related Cutaneous Adverse Events: A Case Series of Four Patients

    Osman A, Zhang C, … senior author Mittal L

  39. 76568

    Treatment of drug reaction with eosinophilia and systemic symptoms with tofacitinib: a pilot study with dynamic cytokines profiles investigation

    Lin WC, Chung WH, Chen CB

  40. 76578

    Cutaneous Adverse Drug Reactions and Drug Hypersensitivity in Pediatric Emergency Visits: A National Electronic Injury Surveillance System Analysis in the United States, 2022–2024

    Quan I, Wu S, Lio P

  41. 76646

    Cutaneous Adverse Reactions and Antibody-Drug Conjugates: A FAERS 2019-2025 Disproportionality Analysis

    Cassidy C, Austin E, Feig JL

  42. 76830

    Differences in the Clinical Features, Treatments, and Organ Involvement of DRESS by RegiSCAR Score: A Retrospective Cohort Study

    Biba U, Salloum L, … senior author Mostaghimi A

  43. 76866

    Modulating the JAK–STAT pathway reduces cytotoxic T-lymphocyte activation in the treatment of Stevens–Johnson syndrome and toxic epidermal necrolysis

    Chen CB, Lin WC

  44. 76876

    Retrospective age-based phenotyping of DRESS syndrome in a cohort of 185 patients

    Biba U, Dewey E, … senior author Mostaghimi A

  45. 77049

    Dermatologic adverse events with bispecific T-cell engager therapies

    Patil M, Wang B, Shi C

  46. 77356

    Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a systematic review of causative agents, management strategies, and long-term outcomes

    Shojaei D, Zabihi H, … senior author Sibbald C

  47. 77563

    Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a systematic review of causative agents, management strategies, and long-term outcomes

    Shojaei D, Zabihi H, … senior author Sibbald C

That's every abstract.